ROMANO KATHRYN (CIK 1801385) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Buy KRYS (7,500 shares), Sell KRYS (3,262 shares), Buy KRYS (550 shares), Sell KRYS (240 shares), Sell KRYS (750 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | Buy | 7,500 | $0 |
| 2026-03-03 | Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | Sell | 3,262 | $899,138 |
| 2026-03-03 | Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | Buy | 550 | $0 |
| 2026-03-03 | Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | Sell | 240 | $66,154 |
| 2026-03-03 | Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | Sell | 750 | $200,700 |
| 2026-02-11 | Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | Buy | 12,500 | $794,375 |
| 2026-02-11 | Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | Sell | 2,000 | $541,120 |
| 2026-02-11 | Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | Sell | 5,700 | $1.5M |
| 2026-02-11 | Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | Sell | 2,824 | $769,568 |
| 2026-02-11 | Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | Sell | 928 | $254,003 |
| 2026-02-11 | Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | Sell | 552 | $151,601 |
| 2026-02-11 | Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | Sell | 400 | $110,272 |
| 2026-02-11 | Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | Sell | 96 | $26,676 |
| 2026-02-11 | Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | Sell | 750 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-03-03